Oral Lamivudine for Extended HIV Postnatal Prophylaxis. [PDF]
Van de Perre P +8 more
europepmc +1 more source
Toxicity of the Antiretrovirals Lamivudine, Dolutegravir, and Tenofovir on the Microalga <i>Chlorella vulgaris</i>. [PDF]
Souza-Silva G +8 more
europepmc +1 more source
Hepatitis B Virus Reactivation in People With HIV After Treatment With Non-hepatitis B Virus-Active Antiretroviral Therapy. [PDF]
Mohareb AM, Boyd A.
europepmc +1 more source
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort). [PDF]
Palich R +6 more
europepmc +1 more source
Comparative evaluation of human T lymphocytes in HIV patients treated with lamivudine + zidovudine combined with nevirapine versus efavirenz. [PDF]
Zhu X, Zou M.
europepmc +1 more source
A novel all-in-one injectable composed of tenofovir alafenamide-dolutegravir-lamivudine exhibits long-acting plasma and cell drug persistence for 8 weeks. [PDF]
Stephen ZR +11 more
europepmc +1 more source
Temporal shifts in antiretroviral therapy regimens and metabolic outcomes in people living with HIV: A systematic review and meta-analysis. [PDF]
Mahanani MR +7 more
europepmc +1 more source
Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. [PDF]
van Dyk J +11 more
europepmc +1 more source
Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report. [PDF]
Mercado J +4 more
europepmc +1 more source
Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study. [PDF]
Philibert P +7 more
europepmc +1 more source

